Xiuwen Li, Bo Tian, Mengyan Liu, Chunlei Miao, Di Wang: Adult-type granulosa cell tumor of the ovary. Am J Cancer Res 2022;12(8):3495-3511. (Full text, PDF)
Kexin Feng, Ziqi Jia, Gang Liu, Zeyu Xing, Jiayi Li, Jiaxin Li, Fei Ren, Jiang Wu, Wenyan Wang, Jie Wang, Jiaqi Liu, Xiang Wang: A review of studies on omitting surgery after neoadjuvant chemotherapy in breast cancer. Am J Cancer Res 2022;12(8):3512-3531. (Full text, PDF)
Kangsheng Liu, Xiaodong Mao, Taiping Li, Zhirong Xu, Ruifang An: Immunotherapy and immunobiomarker in breast cancer: current practice and future perspectives. Am J Cancer Res 2022;12(8):3532-3547. (Full text, PDF)
Yi Li, Pei-Jun Liu, Zhuo-Li Zhang, Yi-Ning Wang: Cardiac imaging techniques for the assessment of immune checkpoint inhibitor-induced cardiotoxicity and their potential clinical applications. Am J Cancer Res 2022;12(8):3548-3560. (Full text, PDF)
Xiao Li, Zhaosheng Ma, Linhang Mei: Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer. Am J Cancer Res 2022;12(8):3561-3580. (Full text, PDF)
Zhifang Deng, Peiyan Zhan, Ke Yang, Li Liu, Jue Liu, Wenqi Gao: Identification of personalized neoantigen-based vaccines and immune subtype characteristic analysis of glioblastoma based on abnormal alternative splicing. Am J Cancer Res 2022;12(8):3581-3600. (Full text, PDF)
Yi-Ping Lee, Wei-Ru Huang, Wun-Syuan Wu, Yuan-Hua Wu, Sheng-Yow Ho, Ying-Jan Wang, Bu-Miin Huang: Cordycepin enhances radiosensitivity to induce apoptosis through cell cycle arrest, caspase pathway and ER stress in MA-10 mouse Leydig tumor cells. Am J Cancer Res 2022;12(8):3601-3624. (Full text, PDF)
Song Li, Yijie Lu, Yaopeng Xu, Cong Zhang, Biren Liu, Ancheng Qin, Zhiming Qiao, Cong Shen, Jun Shen, Yuting Liang, Jianwu Wu, Xinwei Jiang: Brachyury promotes proliferation and migration of hepatocellular carcinoma via facilitating the transcription of NCAPG2. Am J Cancer Res 2022;12(8):3625-3643. (Full text, PDF)
Zhenwang Zhang, Wu Liu, Xiajun Bao, Tian Sun, Jiawei Wang, Mengxi Li, Chao Liu: USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1. Am J Cancer Res 2022;12(8):3644-3661. (Full text, PDF)
Hongwei Lin, Yanjun Gao, Kang Sun, Qian Zhang, Yujuan Li, Min Chen, Faguang Jin: COA3 overexpression promotes non-small cell lung cancer metastasis by reprogramming glucose metabolism. Am J Cancer Res 2022;12(8):3662-3678. (Full text, PDF)
Gang Peng, Yibo Xi, Chiara Bellini, Kien Pham, Zhen W Zhuang, Qin Yan, Man Jia, Guilin Wang, Lingeng Lu, Moon-Shong Tang, Hongyu Zhao, He Wang: Nicotine dose-dependent epigenomic-wide DNA methylation changes in the mice with long-term electronic cigarette exposure. Am J Cancer Res 2022;12(8):3679-3692. (Full text, PDF, Tables S1, S2, S3)
Zhenhua Liu, Jingjing Xiao, Ning Wang, Jie Ding: LSD1 regulates the FOXF2-mediated Wnt/β-catenin signaling pathway by interacting with Ku80 to promote colon cancer progression. Am J Cancer Res 2022;12(8):3693-3712. (Full text, PDF, Table S1)
Jinliang Ni, Yidi Wang, Haixian Zhang, Keyi Wang, Wei Song, Ming Luo, Jianping Che, Jiang Geng, Yunfei Xu, Xudong Yao, Junhua Zheng, Ming Chen, Bo Peng, Weipu Mao: Combination of preoperative plasma fibrinogen and neutrophil-to-lymphocyte ratio to predict the prognosis for patients undergoing laparoscopic nephrectomy for renal cell carcinoma. Am J Cancer Res 2022;12(8):3713-3728. (Full text, PDF)
Jiancai Wang, Xiang Sun, Jiayuan Wang, Kun Zhang, Yiyi Yuan, Yan Guo, Libo Yao, Xia Li, Lan Shen: NDRG2 inhibits pyruvate carboxylase-mediated anaplerosis and combines with glutamine blockade to inhibit the proliferation of glioma cells. Am J Cancer Res 2022;12(8):3729-3744. (Full text, PDF, Supplementary Table 3)
Jifu E, Zhengchun Kang, Jie Yuan, Zhaoming Wang, Dafeng Tong, Junjie Xing: ZNF516 suppresses stem cell-like characteristics by regulating the transcription of Sox2 in colorectal cancer. Am J Cancer Res 2022;12(8):3745-3759. (Full text, PDF)
Yuhao Yuan, Qing Liu, Ziyi Wu, Wei Zhong, Zili Lin, Wei Luo: TXNIP inhibits the progression of osteosarcoma through DDIT4-mediated mTORC1 suppression. Am J Cancer Res 2022;12(8):3760-3779. (Full text, PDF)
Xiyi Wei, Xi Zhang, Shuai Wang, Yichun Wang, Chengjian Ji, Liangyu Yao, Ninghong Song: PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma. Am J Cancer Res 2022;12(8):3780-3798. (Full text, PDF)
Yue-Ju Li, Cheng-Ning Yang, Mark Yen-Ping Kuo, Wei-Ting Lai, Tai-Sheng Wu, Been-Ren Lin: ATMIN enhances invasion by altering PARP1 in MSS colorectal cancer. Am J Cancer Res 2022;12(8):3799-3810. (Full text, PDF)
Dechao Feng, Xu Shi, Jia You, Qiao Xiong, Weizhen Zhu, Qiang Wei, Lu Yang: A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer. Am J Cancer Res 2022;12(8):3811-3828. (Full text, PDF)
Ming-Yue Yao, Ya-Fang Wang, Yu Zhao, Li-Jun Ling, Ye He, Jie Wen, Ming-Yue Zheng, Hua-Liang Jiang, Cheng-Ying Xie: BCL-2 inhibitor synergizes with PI3Kδ inhibitor and overcomes FLT3 inhibitor resistance in acute myeloid leukaemia. Am J Cancer Res 2022;12(8):3829-3842. (Full text, PDF)
Laibang Luo, Xuyang Wang, Huaxiang Wang, Chengkai Yang, Youfu Zhang, Xinchang Li, Zhidan Xu: High cathepsin A protein expression predicts poor prognosis and tumor recurrence of hepatocellular carcinoma patients after curative hepatectomy. Am J Cancer Res 2022;12(8):3843-3856. (Full text, PDF)
Xin Wan, Wei Guo, Xingtong Wang, Jia Li, Yangzhi Zhao, Xiaomeng Feng, Ken H Young, Ou Bai: Improving the prognostic ability of PET/CT SUVmax to identify follicular lymphoma with early treatment failure. Am J Cancer Res 2022;12(8):3857-3869. (Full text, PDF)
Xuyu Gu, Shiyou Wei, Bing Chen, Wentian Zhang, Shiya Zheng: Development and validation of a combined ferroptosis- and pyroptosis-related gene signatures for the prediction of clinical outcomes in lung adenocarcinoma. Am J Cancer Res 2022;12(8):3870-3891. (Full text, PDF, Tables S3, S4)
Zetao Chen, Yujie Zhang, Yihong Chen, Wanmei Lin, Yuxuan Zhang, Guixing Cai, Xinlin Sun, Kehong Zheng, Jie He, Tianjing Ai, Jihui Wang, Liang Zhao, Yiquan Ke: Prrx1 promotes resistance to temozolomide by upregulating ABCC1 and inducing vasculogenic mimicry in glioma. Am J Cancer Res 2022;12(8):3892-3912. (Full text, PDF)
Xunxi Lu, Zongchao Gou, Luoting Yu, Hong Bu: A novel risk model based on immune response predicts clinical outcomes and characterizes immunophenotypes in triple-negative breast cancer. Am J Cancer Res 2022;12(8):3913-3931. (Full text, PDF)
Chun-Te Ho, Shih-Pei Lin, Ling-Ming Tseng, Mien-Chie Hung, Shih-Chieh Hung: Snail induces dormancy in disseminated luminal type A breast cancer through Src inhibition. Am J Cancer Res 2022;12(8):3932-3946. (Full text, PDF)
Xiaochen Qi, Jin Wang, Xiangyu Che, Quanlin Li, Xiaowei Li, Qifei Wang, Guangzhen Wu: The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma. Am J Cancer Res 2022;12(8):3947-3966. (Full text, PDF)
Manon Pillai, Yizhou Jiang, Paul C Lorigan, Fiona C Thistlethwaite, Martine Thomas, Natalia Kirillova, John S Bridgeman, Gray Kueberuwa, Sunetra Biswas, Peter Velazquez, David Chonzi, Ryan D Guest, Zachary J Roberts, Robert E Hawkins: Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma. Am J Cancer Res 2022;12(8):3967-3984. (Full text, PDF)
Ling Chen, Chang-Shun Yang, Si-Dong Chen, Qiao-Xia Zhou, Guo-Qiang Wang, Shang-Li Cai, Wei-Hua Li, Hong-Zhi Luo: Multi-omics characterization of the unsaturated fatty acid biosynthesis pathway in colon cancer. Am J Cancer Res 2022;12(8):3985-4000. (Full text, PDF)
Masanori Oshi, Joy Sarkar, Yoshihisa Tokumaru, Li Yan, Takashi Kosaka, Hirotoshi Akiyama, Masayuki Nagahashi, Chikara Kunisaki, Itaru Endo, Kazuaki Takabe: Higher intra-tumoral expression of pro-coagulation genes is a predictor of angiogenesis, epithelial mesenchymal transition and worse patient survival in gastric cancer. Am J Cancer Res 2022;12(8):4001-4014. (Full text, PDF)
Mohamed S A Gaballah, Hamdy E A Ali, Zeinab A Hassan, Shahenda Mahgoub, Hamid I Ali, Johng S Rhim, Mourad Zerfaoui, Khalid A El Sayed, David Stephen, Paul W Sylvester, Zakaria Y Abd Elmageed: Small extracellular vesicle-associated miR-6068 promotes aggressive phenotypes of prostate cancer through miR-6068/HIC2/SIRT1 axis. Am J Cancer Res 2022;12(8):4015-4027. (Full text, PDF)
Swagoto Mukhopadhyay, Yoshihisa Tokumaru, Masanori Oshi, Itaru Endo, Kazuhiro Yoshida, Kazuaki Takabe: Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival. Am J Cancer Res 2022;12(8):4028-4039. (Full text, PDF)
Xiangxiang Yin, Yuhang Cheng, Senbang Yao, Junxu Wu, Shaochun Liu, Wen Li, Sheng Yu, Lingxue Tang, Yanyan Jing, Lulian Pang, Huaidong Cheng: Fear of cancer recurrence is related to the efficacy of immunotherapy and quality of life in patients with NSCLC during the COVID-19 pandemic in China. Am J Cancer Res 2022;12(8):4040-4049. (Full text, PDF)
Young Hyo Choi, Yong-Moon Park, Kyung Jae Hur, U-Syn Ha, Sung-Hoo Hong, Ji Youl Lee, Sae Woong Kim, Kyungdo Han, Seung Hyun Ko, Yong Hyun Park: Duration of diabetes mellitus and risk of kidney and bladder cancer: a longitudinal nationwide cohort study. Am J Cancer Res 2022;12(8):4050-4061. (Full text, PDF)
Xiaojie Zhang, Chongyuan Sun, Zefeng Li, Tongbo Wang, Lulu Zhao, Penghui Niu, Chunguang Guo, Xu Che, Yingtai Chen, Dongbing Zhao: Long-term survival and pattern of recurrence in ampullary adenocarcinoma patients after curative Whipple’s resection: a retrospective cohort study in the National Cancer Center in China. Am J Cancer Res 2022;12(8):4062-4073. (Full text, PDF)
Hengrui Liu: Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res 2022;12(8):4074-4081. (Full text, PDF)
Retraction: MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA. Am J Cancer Res 2022;12(8):4082. (Full text, PDF)
